Free Notice to Take Deposition - District Court of Delaware - Delaware


File Size: 104.5 kB
Pages: 4
Date: December 31, 1969
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 665 Words, 4,479 Characters
Page Size: 613 x 792 pts
URL

https://www.findforms.com/pdf_files/ded/34913/87.pdf

Download Notice to Take Deposition - District Court of Delaware ( 104.5 kB)


Preview Notice to Take Deposition - District Court of Delaware
Case 1 :05-cv-00349—GI\/IS Document 87 Filed 08/31/2006 Page 1 of 4
IN THE UNITED STATES DISTRICT COURT ‘
FOR THE DISTRICT OF DELAWARE
TALECRIS BIOTHERAPEUTICS, INC., and )
BAYER HEALTHCARE LLC, )
)
Plaintiffs, )
)
v. ) C.A. No. 05-349-GMS
)
BAXTER INTERNATIONAL INC., and ) Jug Trial Demanded
BAXTER HEALTHCARE CORPORATION, )
)
Defendants. )
)
BAXTER HEALTHCARE CORPORATION, )
)
Counterclaimant, )
)
V- )
)
TALECRIS BIOTHERAPEUTICS, INC., and )
. BAYER HEALTHCARE LLC, )
)
? Counterdefendants. )
_ )
PLATNTIFFS’ SECOND NOTICE OF DEPOSITION TO BAXTER INTERNATIONAL
INC. AND BAXTER HEALTHCARE CORPORATION
PURSUANT TO I·`ED.R.CIV.P. 30gb)g6)
_ TO ALL PARTIES AND THEIR COUNSEL OF RECORD:
PLEASE TAKE NOTICE that, pursuant to Rule 30(b)(6) of the Federal Rules of Civil
Procedure, beginning on September 20, 2006 at 9:30 a.rn., at the offices of Bird & Bird, Avenue
d’Auderghem 22-28, Brussels l040, Belgium, counsel for Plaintiffs Talecris Biotherapeutics, inc.
and Bayer Healthcare LLC will take the deposition upon oral examination of Defendant Baxter
International Inc. by and through one or more of its ofticers, directors, or managing agents, or
other persons who are designated and consent to testify on its behalf, with respect to the matters

Case 1:05-cv-00349—Gl\/IS Document 87 Filed 08/31/2006 Page 2 of 4
described in Schedule A hereto. The person or persons so designated shall testify as to matters
known or reasonably available to Defendant.
The deposition will be taken before an ofticer authorized to administer oaths and will
continue from hour to hour and day to day until completed. You are invited to attend and cross-
examine. Please be advised that this deposition may be recorded by videotape in addition to
stenographic recording, which will include the use of LiveNote real time transcription.
A ir_r -- ‘
ugust ’ 6
Bradford J. Badke * effrey B. Bove (#998)
Gabrielle Ciuffreda Mary W. Bourke (#23 56)
ROPES & GRAY LLP l\/lark E. Freeman (#425 7)
1251 Avenue ofthe Americas Jaclyn lvl. Mason (#4737)
New York, NY 10020-l105 CONNOLLY BOVE LODGE & HUTZ LLP
(212) 5969000 The Nemours Building
1007 North Orange Street
Attorneys for Bayer Wilmington, DE 19801
? Healthcare LLC (302) 658~9l41
Attorneys for T ulecris Biothempeutics, Inc.
l and Bayer Healthcare LLC

Case 1:05-cv-00349—Gl\/IS Document 87 Filed 08/31/2006 Page 3 of 4
EXHIBIT A
DEFINITIONS
Except as otherwise provided herein, Plaintiffs hereby incorporate by reference all
deiinitions and instructions set forth in Plaintiffs’ First Set of Requests for Documents and
Things and Plaintiffs’ First Set of Interrogatories (Nos. l—8) as though fully set forth herein.
l. "FDA" means the United States Food and Drug Administration, any of its subdivision
agencies, including the Center for Biologics Evaluation and Research, and any foreign reguiatory
entity charged with government regulatory authority over immune globulin, plasrna·—derived
products, or biological products or intended or used for human or animal administration.
DEPOSITION CATEGORIES
l. The manufacturing processes for GAMMAGARD® S/D, GAl\/lMAGARD® Liquid, and
KIOVIG, specifically including all portions of the manufacturing process that are non—
continuous, and any periods where products or intermediates are held prior to a future step,
I including, but not limited to, the identity of any products or product intermediates that are held,
including the conditions under which the products or intermediates are held, and the effects such
Q hold periods have on the physical or chemical properties of the product or intermediate.

Case 1:05-cv-00349—G|\/IS Document 87 Filed 08/31/2006 Page 4 of 4
CERTIFICATE OF SERVICE
I, JEFFREY B. BOVE, ESQUIRE, do hereby certify that I caused a true copy of the
foregoing document PLAINTH+`FS’ SECOND NOTICE OF DEPOSITION TO BAXTER
INTERNATIONAL INC. PURSUANT TO IÂ¥`ED.R.CIV.P. 30gb)g6), to be served upon the
below listed inthe manner indicated on August 31, 2006.
Via Hand Delivegy and EE—Mail
Philip A. Rovner, Esquire
Potter Anderson & Corroon LLP
Hercules Plaza
P. O. Box 951
Wilmington, DE 19899
(302) 984-6140
Via Federal Express and E-Mail
Susan Spaeth, Esquire
Townsend and Townsend and Crew LLP
379 Lytton Avenue
Palo Alto, CA 94301—143l
(415) 576-0200 /
_ : e, Esquire (# 998)
4ss9uv_1.noc